Over the years several drugs have been tested for the treatment of canine Cushing’s syndrome. Mitotane is an adrenolytic drug that is very effective but not very “wieldy“, it was the drug most widely used in the past. For more than 10 years it has being available trilostane, an enzyme inhibitor which has been demonstrated to be effective in the treatment of this endocrinopathy and it is officially approved for the treatment of canine hypercortisolism. In this review the therapeutic approach to canine Cushing’s syndrome with particular

Terapia medica della Sindrome di Cushing nel cane

CORRADINI, SARA;MALERBA, ELEONORA GLENDA MARIA;FRACASSI, FEDERICO
2014

Abstract

Over the years several drugs have been tested for the treatment of canine Cushing’s syndrome. Mitotane is an adrenolytic drug that is very effective but not very “wieldy“, it was the drug most widely used in the past. For more than 10 years it has being available trilostane, an enzyme inhibitor which has been demonstrated to be effective in the treatment of this endocrinopathy and it is officially approved for the treatment of canine hypercortisolism. In this review the therapeutic approach to canine Cushing’s syndrome with particular
2014
Sara, Corradini; Eleonora, Glenda Maria Malerba; Federico Fracassi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/550257
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact